Philips Leads Large Scale eHealth Initiative to Deliver Coordinated Care for Tens of Thousands of Chronic Disease Patients across Europe

PhilipsRoyal Philips (NYSE: PHG; AEX: PHIA) and a consortium of leading European healthcare regions, companies, universities and hospitals today announced the start of the first large scale care coordination and telehealth program in the European Union to support tens of thousands of people living with chronic conditions. The three-year ACT@Scale program will collect and analyze the health outcome and economic impact data for large populations of chronic patients and elderly people to develop, test and consolidate 'best practice' care coordination and telehealth programs that can be replicable and successfully rolled out across the European Union. The program aims to reach more than 75,000 patients in the United Kingdom, the Netherlands, Spain and Denmark by 2019.

"Today, 70 percent of Europe's healthcare budget is spent on patients living with chronic conditions, largely a result of Europe's aging population and rapidly changing care needs," said Jeroen Tas, CEO Connected Care and Health Informatics, Philips. "Philips is committed to helping care providers and governments implement innovative, connected care delivery models that help improve patient self-management and care collaboration. The ACT@Scale program will provide the evidence needed to successfully deliver a seamless patient experience with better outcomes at lower cost."

The five participating healthcare regions are all in the process of rolling out innovative care coordination and telehealth services. Within the ACT@Scale program, they will share an agreed and standardized data set including program outcomes such as the number of patients included, (re)hospitalizations, duration of hospitalizations and mortality rates. They will also assess economic impact factors such as cost per patient and the impact on hospitals income models. This data is to support the development of new and sustainable business models. Next to this patient satisfaction scores are measured and the degree to which connected technology empowers people and affects health outcomes.

The regions involved comprise Catalonia (Spain), which has developed programs to support nursing homes, reduce hospital re-admissions, manage complex cases and promote physical activity; Southern Denmark (Denmark), which is rolling out a telehealth program to deliver psychiatric treatment; Northern Ireland (UK), which has remote telemonitoring programs to support COPD and diabetes patients, and manage maternal obesity; Northern Netherlands (The Netherlands), with programs to provide specialist support for COPD, asthma and heart failure patients, and connect healthcare and community services for chronic disease patients; and the Basque Country (Spain), which is rolling out programs to support older people with complex health and social care needs, plus telehealth services for chronic heart failure patients.

"Telehealth and coordinated care services may offer the elderly and otherwise frail individuals the ability to maintain their independence for longer and enjoy a significantly better quality of life, but they also involve significant changes to the healthcare system and the recipients' ability to self-manage," said Professor Erik Buskens, Professor of Medical Technology Assessment at University Medical Center Groningen (UMCG). "ACT@Scale will allow us to determine the most cost-effective ways of implementing those changes while also maximizing the benefits for Europe’s ageing population."

First findings available end of year
The ACT@Scale scientific consortium members comprise of University Medical Center Groningen (The Netherlands), Aristotle University of Thessaloniki (Greece), City University London (UK), Universitätsklinikum Würzburg/Klinikum der Bayerischen Julius-Maximilians-Universität (Germany), University of Hull (UK), Kronikgune-Centre for Research Excellence in Chronicity (Basque Country, Spain), Hospital Clinic of Barcelona (Spain) and Philips. It is anticipated that the first preliminary findings will be available from the end of Q4, 2016.

ACT@Scale builds on the successful ACT program, a two-and-a-half year study (2013 - 2016) that looked into the results of European integrated care programs. Thousands of interviews were conducted with participating patients and care providers. These learnings on success factors are applied to significantly grow the ACT@Scale healthcare regions' coordination and telehealth programs. The program is part of the European Innovation Partnership on Active and Healthy Ageing (EIP-AHA), an initiative from the European Commission under its Innovation Union strategy, and aims to increase the average healthy lifespan by two years by 2020.

eHealth Week 2016
Philips, a leader in care coordination and telehealth and a trusted partner for governments, healthcare authorities and hospitals throughout the world, will be showcasing its latest eHealth and coordinated care solutions at the upcoming eHealth Week, booth N21, Hall 2 (June 8 - 10, Beurs van Berlage, Amsterdam, The Netherlands).

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ wholly owned subsidiary Philips Lighting is the global leader in lighting products, systems and services. Headquartered in the Netherlands, Philips posted 2015 sales of EUR 24.2 billion and employs approximately 104,000 employees with sales and services in more than 100 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...